Evangelos Dadiotis is a Postdoctoral Researcher at Northeastern University specializing in natural products and ion channel pharmacology. His research focuses on the pharmacological potential of psychedelics and cannabinoids, particularly their interaction with TRPA1 and related ion channels. He combines electrophysiology, NMR, and computational tools to explore mechanisms of action. He is also co-founder of Ekati Biotech and investigates ancient psychedelic preparations like Kykeon, bridging ethnobotany with modern psychedelic science.

Experienced and self-motivated interdisciplinary researcher with dual M.Sc. degrees in Agricultural Engineering and Pharmacognosy, specializing in the Chemistry of Natural Products. Possesses over five years of hands-on experience in analytical and biological laboratories, as well as in R&D settings across universities, research institutions, and the pharmaceutical industry. His research focuses on psychoactive natural products, with an emphasis on indole alkaloids and cannabinoids. His work integrates phytochemistry, biotechnology, and ethnobotany, aiming to bridge ancient psychopharmacognosy with modern scientific understanding. He is currently developing his research into a PhD thesis titled “Development of methods for the analysis of indole alkaloids with emphasis on substituted tryptamines and ergoline derivatives of natural origin and evaluation of their pharmacological activity and toxicity

Eleana Baskouta is a cultural strategist, development advisor, and interdisciplinary researcher working at the intersection of psychedelic science and cultural anthropology. With a decade of experience in international development and philanthropic strategy, she specializes in building research ecosystems that bridge scientific inquiry with cultural integrity.

As Co-Founder and Strategic Development Director of ELKEEN Eleana contributes to the institute’s strategic vision, resource development, and global partnerships. Her work is grounded in an ethical commitment to the philosophical and ceremonial legacy of the ancient Greek Mysteries. She advocates for a revival of entheogenic research that honors epistemic humility, ecological reverence, and cultural sovereignty—ensuring that Greece’s historical relationship with sacred pharmacology is not appropriated, but restored with rigor and respect. She holds a Master’s in Development Economics and International Relations from The Fletcher School at Tufts University, a B.Sc. in Business & Economics from the American College of Greece, and a B.A. in Cultural Anthropology from the University of Athens.

Dr. Vangelis Mitsis is a Greek physician and multidisciplinary researcher specializing in natural products, with a strong focus on cannabis and entheogens. He holds a degree in General Medicine from the University of Padua, Italy, and has led pioneering work in applied biotechnology, phytochemistry, and pharmacognosy. As founder of Ekati Alchemy Lab SL (Spain), and co-founder of Ekati Biotech (Greece) and Entheogen Biotech (Canada/Jamaica), Dr. Mitsis has contributed extensively to the development of novel therapeutic applications. His cannabis research includes in vitro micropropagation, molecular marker profiling, and patented innovations in cannabinoid derivatives. His current work with Entheogen Biotech explores psilocybin-producing mushrooms for the treatment of depression and addiction through environmentally controlled bioreactor cultivation and cross-continental academic collaborations with institutions in Greece, the USA, Canada, and Jamaica. Through a combination of clinical expertise, laboratory innovation, and international scientific engagement, Dr. Mitsis stands at the forefront of translational research in plant- and fungi-based medicines.